Ubs Group Ag Molecular Partners Ag Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Molecular Partners Ag stock. As of the latest transaction made, Ubs Group Ag holds 5,246 shares of MOLN stock, worth $27,541. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,246
Previous 3,461
51.57%
Holding current value
$27,541
Previous $25,000
4.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MOLN
# of Institutions
6Shares Held
849KCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA443KShares$2.33 Million0.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY400KShares$2.1 Million0.08% of portfolio
-
Morgan Stanley New York, NY500Shares$2,6250.0% of portfolio
-
Rhumbline Advisers Boston, MA269Shares$1,4120.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $171M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...